Recognition places pharmaceutical excipients leader among the top 5% of companies globally, highlighting progress in emissions reduction, responsible sourcing, and sustainable supply chain practices
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
Lupin attained a score of 91 out of 100, establishing itself as the leading pharmaceutical company globally
Profitability metrics showed a sharper upward trend. Gross margin expanded 280 basis points to 61.2%
Yearbook members are selected basis their S&P Global 2024 Corporate Sustainability Assessment score
This Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability
Biocon’s subsidiary Biocon Biologics Limited, which also participated independently in the assessment for the first time, reported an S&P Global ESG Score of 53
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
Sustainability is integral to Biocon's business purpose
This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
